Tourette Syndrome Clinical Trials

Find Tourette Syndrome Clinical Trials Near You

Exploring the Role of Neuroactive Steroids in Tourette Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Tourette syndrome (TS) is a disabling neurodevelopmental disorder characterized by motor and phonic tics. The studies proposed in this application will explore the endocrine mechanisms underlying two of the least well-understood biological characteristics of TS, namely its marked male predominance and stress susceptibility. In particular, our exploratory studies will characterize the steroid profile in TS-affected boys and girls to identify novel potential biomarkers and therapeutic targets for this disorder.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 12
Healthy Volunteers: t
View:

• Diagnostic criteria of TS for cases (and lack of any tic disorders for controls)

• Age between 8 and 12 years old (this age range is to ensure that TS participants can perform the tic suppression task)

• confirmation of sexual development by parent and/or self-reported Tanner stage of pubic hair development.

Locations
United States
Utah
University of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Marco Bortolato, MD PhD
marco.bortolato@utah.edu
8015873352
Backup
Michael Himle, PhD
michael.himle@utah.edu
8015817529
Time Frame
Start Date: 2023-05-15
Estimated Completion Date: 2027-10-31
Participants
Target number of participants: 120
Treatments
Experimental: Tic suppression
Children with tics will undergo a tic suppression experimental paradigm.
Sponsors
Leads: University of Utah
Collaborators: University of Miami, Albert Einstein College of Medicine

This content was sourced from clinicaltrials.gov